Concepedia

Publication | Open Access

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses

95

Citations

34

References

2024

Year

References

YearCitations

Page 1